Hongbo Lu - 07 Sep 2022 Form 4 Insider Report for Terns Pharmaceuticals, Inc. (TERN)

Role: Director
Signature: /s/ Bryan Yoon, as Attorney-in-Fact for Hongbo Lu
Issuer symbol: TERN
Transactions as of: 07 Sep 2022
Net transactions value: +$2,160,000
Form type: 4
Filing time: 08 Sep 2022, 20:00:37 UTC
Previous filing: 16 Aug 2022
Next filing: 23 Dec 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TERN	Common Stock	Purchase	$2,160,000	+600,000	+20%	$3.60	3,581,592	07 Sep 2022	See Footnote	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The securities are held of record by Vivo Opportunity Fund Holdings, L.P. Vivo Opportunity, LLC is the general partner of Vivo Opportunity Fund Holdings, L.P. As a managing member of Vivo Opportunity, LLC, Hongbo Lu shares voting and dispositive power over the securities held by Vivo Opportunity Fund Holdings, L.P. with four other managing members but disclaims beneficial ownership over such securities except to the extent of her pecuniary interest therein.

Content

The securities are held of record by Vivo Opportunity Fund Holdings, L.P. Vivo Opportunity, LLC is the general partner of Vivo Opportunity Fund Holdings, L.P. As a managing member of Vivo Opportunity, LLC, Hongbo Lu shares voting and dispositive power over the securities held by Vivo Opportunity Fund Holdings, L.P. with four other managing members but disclaims beneficial ownership over such securities except to the extent of her pecuniary interest therein.